Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01737151 · ClinicalTrials.gov registry record · NA
Stereotactic Body Radiation Therapy in Treating Patients With Low- and Intermediate-Risk Prostate Cancer
A NA study, sponsored by Virginia Commonwealth University.
- Terminated
- Registry status
- NA
- Development phase
- 19
- Enrollment target
NCT01737151 is a NA study that was terminated before completion, run by Virginia Commonwealth University. The registered enrollment target is 19 participants.
The verdict
NCT01737151, a NA study, was terminated before completion, sponsored by Virginia Commonwealth University.
- TERMINATED
- Registry status
- NA
- Development phase
- 19 participants
- Enrollment target
Study Summary
This clinical trial studies stereotactic body radiation therapy in treating patients with low- and intermediate-risk prostate cancer. Stereotactic body radiation therapy may be able to send x-rays directly to the tumor and cause less damage to normal tissue.
Interventions
- RADIATION stereotactic body radiation therapy
- RADIATION four fraction split-course SBRT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2013-03-08 |
| Est. Completion | 2017-11-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01737151
The ClinicalTrials.gov registry entry for NCT01737151 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Virginia Commonwealth University, which has 558 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which stereotactic body radiation therapy is the first listed.
NCT01737151 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01737151 about?
NCT01737151 is a clinical study titled "Stereotactic Body Radiation Therapy in Treating Patients With Low- and Intermediate-Risk Prostate Cancer". This clinical trial studies stereotactic body radiation therapy in treating patients with low- and intermediate-risk prostate cancer. Stereotactic body radiation therapy may be able to send x-rays directly to the tumor and cause less damage to normal tissue.
What is the current status of trial NCT01737151?
This trial is currently terminated. It is a NA study. The enrollment target is 19 participants. The study started on 2013-03-08. Estimated completion is 2017-11-09.
What interventions are being tested in trial NCT01737151?
The interventions under investigation include: stereotactic body radiation therapy (RADIATION), four fraction split-course SBRT (RADIATION).
Who is sponsoring clinical trial NCT01737151?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.